← Leaderboards
Daniel Stuart Talmor
Beth Israel Deaconess Medical Center
$11,223,239
Attributed
$27,118,528
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2011–25$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,733,074 · 11
By mechanism
UM1$10,293,615 · 5
U01$9,006,518 · 2
R01$7,139,993 · 1
UH3$3,847,221 · 2
UG3$1,445,727 · 1
Top collaborators
- Stephen H Loring15 shared
- Edward R Marcantonio7 shared
- Nathan I Shapiro7 shared
- Balachundhar Subramaniam7 shared
- Ognjen Gajic5 shared
- Michelle Ng Gong5 shared
- Jeremy R. Beitler3 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Stephen H Loring$8,124,110
- Edward R Marcantonio$19,902,198
- Balachundhar Subramaniam$4,759,796
- Ira M Cheifetz$3,535,311
- Sarinnapha Vasunilashorn$3,257,145
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsMorbidity - Disease RateLung InjuryLeadEnrollmentLungMedicalCritical IllnessAdult Respiratory Distress SyndromePleuralPositive-Pressure RespirationPressurePreventClinical ResearchBaseCessation Of LifeRandomizedHospitalsPreventionMedical CenterProceduresProtocols DocumentationPhysiologicalAccounting
Grant awards (37)
1/2: PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI)$1,520,511
UH3 · FY2025 · HL · contact PI
Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients (PANDORA) - Administrative Supplement$506,664
R01 · FY2025 · AG
1/2: PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI)$1,517,527
UH3 · FY2024 · HL · contact PI
Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients$837,075
R01 · FY2024 · AG
Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients$1,633,157
R01 · FY2023 · AG
1/2: PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI)$1,445,727
UG3 · FY2023 · HL · contact PI
Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients$1,410,197
R01 · FY2022 · AG
Scheduled prophylactic 6-hourly intravenous acetaminophen to prevent postoperative delirium in older cardiac surgical patients (PANDORA) - Administrative Supplement$117,017
R01 · FY2022 · AG
Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients$1,416,428
R01 · FY2021 · AG
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2020 · HL · contact PI
Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients$1,219,455
R01 · FY2019 · AG
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2019 · HL · contact PI
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2018 · HL · contact PI
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2017 · HL · contact PI
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2016 · HL · contact PI
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$487,358
U01 · FY2015 · HL · contact PI
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$457,591
UH3 · FY2015 · HL
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$351,592
UH3 · FY2015 · HL
EPVent 2-A Phase II Trial Esophageal Pressure Guided Ventilation$1,784,841
UM1 · FY2014 · HL · contact PI
Sub Project 2$777,148
UM1 · FY2014 · HL · contact PI
Sub Project 2$777,145
UM1 · FY2014 · HL · contact PI
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$163,283
U01 · FY2014 · HL · contact PI
Ancillary Study$115,276
UM1 · FY2014 · HL · contact PI
Ancillary Study$115,272
UM1 · FY2014 · HL · contact PI
LIPS-A: Lung Injury Prevention Study with Aspirin$2,217,606
U01 · FY2013 · HL
EPVent 2-A Phase II Trial Esophageal Pressure Guided Ventilation$1,765,182
UM1 · FY2013 · HL · contact PI
Sub Project 2$769,782
UM1 · FY2013 · HL · contact PI
Sub Project 2$769,781
UM1 · FY2013 · HL · contact PI
Ancillary Study$112,810
UM1 · FY2013 · HL · contact PI
Ancillary Study$112,809
UM1 · FY2013 · HL · contact PI
LIPS-A: Lung Injury Prevention Study with Aspirin$2,384,003
U01 · FY2012 · HL
EPVent 2-A Phase II Trial Esophageal Pressure Guided Ventilation$1,064,523
UM1 · FY2012 · HL · contact PI
Sub Project 2$1,002,923
UM1 · FY2012 · HL · contact PI
Sub Project 2$1,002,923
UM1 · FY2012 · HL · contact PI
Ancillary Study$61,600
UM1 · FY2012 · HL · contact PI
Ancillary Study$61,600
UM1 · FY2012 · HL · contact PI
LIPS-A: Lung Injury Prevention Study with Aspirin$1,465,363
U01 · FY2011 · HL